Literature DB >> 10795747

Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.

Y Kiyozuka1, A Asai, D Yamamoto, H Senzaki, S Yoshioka, H Takahashi, K Hioki, A Tsubura.   

Abstract

The telomere and the telomerase in human esophageal cancer are not yet completely understood. The regulatory mechanism of telomerase activity and telomere dynamics has drawn considerable attention. It is generally assumed that when telomerase has been activated, no further telomere shortening should ensue; however, a much more complex pattern of telomere dynamics may exist in telomerase-positive cancer cells. A novel human esophageal cancer cell line (KAN-ES) was established and characterized. Using KAN-ES and its serially passaged subclones up to the 55th generation, we determined the alteration of telomere length (TRF), telomerase activity (TA), telomerase RNA expression (hTR), population doubling time, karyotype, and cytokeratin 14 expression during the process of establishing a cancer cell line. We found that the TRF was maintained between 4.0 and 5.0 kb during the serial passages, despite sustained high TA (assessed by an in vitro TRAP assay). No close relationships were found among TRF, TA, and hTR expression. TA and telomere dynamics were not associated with cellular growth ability and differentiation. However, the number of population doublings showed significant correlations with both the TA and doubling times. In conclusion, these dissociations between telomere dynamics and TA support the existence of additional controls on TRF in cancer cells. KAN-ES and its restored subclones should prove a valuable resource for esophageal cancer research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10795747     DOI: 10.1023/a:1005504503975

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Functional characterization and developmental regulation of mouse telomerase RNA.

Authors:  M A Blasco; W Funk; B Villeponteau; C W Greider
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

2.  Genetic control of chromosome length in yeast.

Authors:  R M Walmsley; T D Petes
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

4.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

5.  Biologic properties of three newly established human esophageal carcinoma cell lines.

Authors:  C P Hu; H G Hsieh; K Y Chien; P Y Wang; C I Wang; C Y Chen; S J Lo; K D Wuu; C M Chang
Journal:  J Natl Cancer Inst       Date:  1984-03       Impact factor: 13.506

6.  Enhanced expression of the multidrug resistance gene in vindesine-resistant human esophageal cancer cells.

Authors:  T Saito; M Hikita; K Kohno; H Tanimura; M Miyahara; M Kobayashi
Journal:  Oncology       Date:  1994 Sep-Oct       Impact factor: 2.935

7.  Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.

Authors:  Y Kiyozuka; A Asai; H Senzaki; Y Uemura; A Nakashima; J Morimoto; A Matsuzawa; A Tsubura
Journal:  Int J Mol Med       Date:  1998-10       Impact factor: 4.101

Review 8.  Telomeres and telomerase in aging and cancer.

Authors:  C B Harley; B Villeponteau
Journal:  Curr Opin Genet Dev       Date:  1995-04       Impact factor: 5.578

9.  Telomere length, telomerase activity and telomerase RNA expression in human esophageal cancer cells: correlation with cell proliferation, differentiation and chemosensitivity to anticancer drugs.

Authors:  A Asai; Y Kiyozuka; R Yoshida; T Fujii; K Hioki; A Tsubura
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

Review 10.  Studies on esophageal cancer cells in vitro.

Authors:  Q Q Pan
Journal:  Proc Chin Acad Med Sci Peking Union Med Coll       Date:  1989
View more
  3 in total

1.  Progressive transformation of immortalized esophageal epithelial cells.

Authors:  Zhong-Ying Shen; Li-Yan Xu; Min-Hua Chen; Jian Shen; Wei-Jia Cai; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

2.  Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.

Authors:  Zhong-Ying Shen; Li-Yan Xu; En-Min Li; Wei-Jia Cai; Min-Hua Chen; Jian Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

3.  Individual patient oesophageal cancer 3D models for tailored treatment.

Authors:  John H Saunders; David Onion; Pamela Collier; Matthew S Dorrington; Richard H Argent; Philip A Clarke; Alex M Reece-Smith; Simon L Parsons; Anna M Grabowska
Journal:  Oncotarget       Date:  2017-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.